> top > docs > PMC:7200337 > spans > 93461-93973 > annotations

PMC:7200337 / 93461-93973 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T727 49-57 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T728 63-72 Body_part denotes chemokine http://purl.org/sig/ont/fma/fma241981
T729 114-117 Body_part denotes CSF http://purl.org/sig/ont/fma/fma20935
T730 127-136 Body_part denotes chemokine http://purl.org/sig/ont/fma/fma241981
T731 305-310 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T732 419-427 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T531 215-223 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T532 224-227 Disease denotes CRS http://purl.obolibrary.org/obo/MONDO_0007399|http://purl.obolibrary.org/obo/MONDO_0017361
T534 314-322 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T535 474-482 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T965 24-33 http://purl.obolibrary.org/obo/SO_0000418 denotes signaling
T966 261-271 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T967 305-310 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T306 19-21 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T308 104-106 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T310 111-113 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120
T311 236-238 Chemical denotes 6C http://purl.obolibrary.org/obo/CHEBI_27594

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T206 24-41 http://purl.obolibrary.org/obo/GO_0007165 denotes signaling pathway
T207 24-33 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T208 104-109 http://purl.obolibrary.org/obo/GO_0004908 denotes IL-1R
T209 250-271 http://purl.obolibrary.org/obo/GO_0006956 denotes complement activation

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
3064 19-23 Gene denotes IL-6 Gene:3569
3065 104-109 Gene denotes IL-1R Gene:3554
3066 111-117 Gene denotes GM-CSF Gene:1437
3067 146-150 Gene denotes CCR5 Gene:1234
3068 404-407 Gene denotes C5a Gene:728
3069 282-284 Gene denotes to Gene:6999
3070 205-207 Gene denotes to Gene:6999
3071 12-14 Gene denotes to Gene:6999
3072 323-331 Species denotes patients Tax:9606
3073 483-491 Species denotes patients Tax:9606
3074 215-223 Disease denotes COVID-19 MESH:C000657245
3075 314-322 Disease denotes COVID-19 MESH:C000657245
3076 459-473 Disease denotes critically ill MESH:D016638
3077 474-482 Disease denotes COVID-19 MESH:C000657245

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T537 0-240 Sentence denotes In addition to the IL-6 signaling pathway, other cytokine- and chemokine-associated elements, including IL-1R, GM-CSF, and the chemokine receptor CCR5, have been proposed as potential targets for blockade to manage COVID-19 CRS (Figure 6C).
T538 241-332 Sentence denotes Finally, complement activation was shown to be overactivated in lungs of COVID-19 patients.
T539 333-512 Sentence denotes Although results from the randomized trial are not yet published, anti-C5a monoclonal antibody therapy showed benefits in two critically ill COVID-19 patients (Gao et al., 2020d).